Literature DB >> 7608270

Expression of exon 3-retaining and exon 3-excluding isoforms of the human growth hormone-receptor is regulated in an interindividual, rather than a tissue-specific, manner.

R B Wickelgren1, K L Landin, C Ohlsson, L M Carlsson.   

Abstract

GH has multiple effects on growth and metabolism, and these functions are mediated through binding to specific cell surface receptors. The human GH receptor (GHR) exists in two known isoforms; in one form exon 3 is present (GHR3+), and in the other, exon 3 is absent (GHR3-). Recent reports have suggested that the expression of the two isoforms is tissue specific and/or developmentally regulated. We used a reverse transcription-polymerase chain reaction assay to study the expression pattern of the two isoforms in a variety of tissues from normal subjects and patients with acromegaly. In skeletal muscle from both normal subjects and patients with acromegaly, the GHR3+ transcript was expressed, either alone or together with the shorter (GHR3-) transcript. When multiple tissues from six subjects were tested, the expression of the two isoforms varied among subjects, whereas different tissues from the same subject showed the same expression pattern. These results indicate that the expression of the GHR isoforms is not tissue specific. Instead, the expression of the GHR isoforms appears to be specific for each individual, suggesting that it is under the control of factors that affect all tissues in the body.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608270     DOI: 10.1210/jcem.80.7.7608270

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism.

Authors:  M L Stallings-Mann; R L Ludwiczak; K W Klinger; F Rottman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

2.  Growth hormone receptor is expressed in human breast cancer.

Authors:  M Gebre-Medhin; L G Kindblom; H Wennbo; J Törnell; J M Meis-Kindblom
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

3.  Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein.

Authors:  F Dastot; M L Sobrier; P Duquesnoy; B Duriez; M Goossens; S Amselem
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

4.  Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly.

Authors:  Antonio Bianchi; Gherardo Mazziotti; Laura Tilaro; Vincenzo Cimino; Flora Veltri; Eleonora Gaetani; Giovanni Pecorini; Alfredo Pontecorvi; Andrea Giustina; Laura De Marinis
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

5.  The clinical and cardiometabolic effects of d3-growth hormone receptor polymorphism in acromegaly.

Authors:  Nese Cinar; Selcuk Dagdelen; Hikmet Yorgun; Ugur Canpolat; Giray Kabakçı; Tomris Erbas
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

6.  The growth hormone receptor gene deleted for exon three (GHRd3) polymorphism is associated with birth and placental weight.

Authors:  Raja Padidela; Sinead M Bryan; Sayeda Abu-Amero; Rebecca E Hudson-Davies; John C Achermann; Gudrun E Moore; Peter C Hindmarsh
Journal:  Clin Endocrinol (Oxf)       Date:  2012-02       Impact factor: 3.478

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.